Northwestern Mutual Investment Management Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2M | Sell |
3,204
-22
| -0.7% | -$15K | 0.02% | 352 |
|
|
2026
Q1 | $2.49M | Buy |
3,226
+6
| +0.2% | +$4.59K | 0.04% | 225 |
|
|
2025
Q4 | $2.49M | Sell |
3,220
-26
| -0.8% | -$17.7K | 0.03% | 223 |
|
|
2025
Q3 | $1.83M | Sell |
3,246
-66
| -2% | -$37.3K | 0.03% | 329 |
|
|
2025
Q2 | $1.74M | Sell |
3,312
-35
| -1% | -$19.5K | 0.03% | 323 |
|
|
2025
Q1 | $2.12M | Buy |
3,347
+4
| +0.1% | +$2.75K | 0.03% | 219 |
|
|
2024
Q4 | $2.38M | Sell |
3,343
-20
| -0.6% | -$16.8K | 0.05% | 184 |
|
|
2024
Q3 | $3.54M | Sell |
3,363
-12
| -0.4% | -$13.4K | 0.08% | 103 |
|
|
2024
Q2 | $3.55M | Buy |
3,375
+23
| +0.7% | +$22.3K | 0.09% | 95 |
|
|
2024
Q1 | $3.23M | Sell |
3,352
-39
| -1% | -$37.1K | 0.08% | 114 |
|
|
2023
Q4 | $2.98M | Buy |
3,391
+22
| +0.7% | +$18.1K | 0.08% | 110 |
|
|
2023
Q3 | $2.77M | Sell |
3,369
-35
| -1% | -$27.5K | 0.08% | 103 |
|
|
2023
Q2 | $2.45M | Buy |
3,404
+24
| +0.7% | +$18.5K | 0.06% | 127 |
|
|
2023
Q1 | $2.78M | Buy |
3,380
+23
| +0.7% | +$17.3K | 0.07% | 101 |
|
|
2022
Q4 | $2.42M | Sell |
3,357
-624
| -16% | -$460K | 0.06% | 104 |
|
|
2022
Q3 | $2.74M | Sell |
3,981
-815
| -17% | -$513K | 0.07% | 95 |
|
|
2022
Q2 | $2.83M | Buy |
4,796
+65
| +1% | +$42.3K | 0.06% | 114 |
|
|
2022
Q1 | $3.3M | Sell |
4,731
-502
| -10% | -$318K | 0.07% | 119 |
|
|
2021
Q4 | $3.31M | Sell |
5,233
-33
| -0.6% | -$20.3K | 0.06% | 139 |
|
|
2021
Q3 | $3.19M | Buy |
5,266
+511
| +11% | +$317K | 0.06% | 135 |
|
|
2021
Q2 | $2.66M | Sell |
4,755
-18
| -0.4% | -$9.12K | 0.05% | 151 |
|
|
2021
Q1 | $2.26M | Sell |
4,773
-981
| -17% | -$478K | 0.04% | 170 |
|
|
2020
Q4 | $2.78M | Buy |
5,754
+213
| +4% | +$115K | 0.04% | 209 |
|
|
2020
Q3 | $3.46M | Hold |
5,541
| – | – | 0.05% | 131 |
|
|
2020
Q2 | $3.46M | Buy |
5,541
+1,383
| +33% | +$785K | 0.05% | 128 |
|
|
2020
Q1 | $2.03M | Buy |
4,158
+1,056
| +34% | +$436K | 0.03% | 201 |
|
|
2019
Q4 | $1.17M | Buy |
3,102
+59
| +2% | +$19.9K | 0.02% | 434 |
|
|
2019
Q3 | $844K | Buy |
3,043
+60
| +2% | +$17.8K | 0.02% | 552 |
|
|
2019
Q2 | $934K | Sell |
2,983
-8,926
| -75% | -$2.97M | 0.02% | 506 |
|
|
2019
Q1 | $4.89M | Buy |
11,909
+217
| +2% | +$89.4K | 0.09% | 192 |
|
|
2018
Q4 | $4.37M | Sell |
11,692
-1,867
| -14% | -$683K | 0.07% | 196 |
|
|
2018
Q3 | $5.48M | Sell |
13,559
-1,252
| -8% | -$476K | 0.08% | 205 |
|
|
2018
Q2 | $5.11M | Buy |
14,811
+755
| +5% | +$236K | 0.08% | 226 |
|
|
2018
Q1 | $4.84M | Sell |
14,056
-3,344
| -19% | -$1.16M | 0.08% | 225 |
|
|
2017
Q4 | $6.54M | Buy |
17,400
+176
| +1% | +$71.3K | 0.11% | 188 |
|
|
2017
Q3 | $7.7M | Sell |
17,224
-261
| -1% | -$124K | 0.13% | 156 |
|
|
2017
Q2 | $8.59M | Buy |
17,485
+2,113
| +14% | +$925K | 0.14% | 138 |
|
|
2017
Q1 | $5.96M | Buy |
15,372
+6,691
| +77% | +$2.48M | 0.11% | 172 |
|
|
2016
Q4 | $3.19M | Buy |
8,681
+1,214
| +16% | +$462K | 0.06% | 187 |
|
|
2016
Q3 | $3M | Buy |
7,467
+4,498
| +151% | +$1.8M | 0.06% | 170 |
|
|
2016
Q2 | $1.04M | Sell |
2,969
-11
| -0.4% | -$4.24K | 0.02% | 270 |
|
|
2016
Q1 | $1.07M | Buy |
2,980
+31
| +1% | +$12.8K | 0.02% | 272 |
|
|
2015
Q4 | $1.6M | Buy |
2,949
+164
| +6% | +$88.9K | 0.03% | 260 |
|
|
2015
Q3 | $1.29M | Buy |
2,785
+65
| +2% | +$34.9K | 0.03% | 309 |
|
|
2015
Q2 | $1.39M | Buy |
2,720
+35
| +1% | +$17.1K | 0.03% | 332 |
|
|
2015
Q1 | $1.21M | Buy |
+2,685
| New | +$1.14M | 0.02% | 374 |
|
Other funds holding REGN
N
Northwestern Mutual Investment Management Company's REGN Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company reduced its Regeneron Pharmaceuticals (REGN) stake by 0.68% in Q2 2026, selling an estimated $15K and leaving 3,204 shares worth $2M. The position accounts for 0.02% of the portfolio, ranked #352.
Northwestern Mutual Investment Management Company first reported a position in REGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $8.59M in Q2 2017. 961 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Northwestern Mutual Investment Management Company held 3,204 shares of Regeneron Pharmaceuticals worth $2M as of Q2 2026.
- Northwestern Mutual Investment Management Company sold 22 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $15K.
- Regeneron Pharmaceuticals made up 0.02% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #352 holding.
- Northwestern Mutual Investment Management Company first reported a position in Regeneron Pharmaceuticals in Q1 2015 and has held it in 46 quarters since.
- Northwestern Mutual Investment Management Company's Regeneron Pharmaceuticals position peaked at $8.59M in Q2 2017.
- 961 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.